Medikra Inc.

Medikra Inc. publicly filed a registration statement on Form F-1 on Jan 20, 2026 for a proposed initial public offering on Nasdaq Global Market under the ticker MDKR, and has not yet priced. Its latest amendment was filed on Feb 13, 2026. The filing shows a price range of $5.00–$6.00 per share. Underwriters named in the filing: Brookline and Arcadia.

Medikra Inc. is a Cayman Islands holding company with subsidiaries in Malaysia, operating as a clinical-stage biopharmaceutical company. It pursues two tracks: near-term revenue from nutraceutical formulations and longer-term development of pharmaceutical-grade botanical therapeutics, with no approved prescription products yet.

Status

Filed, not priced

Ticker

MDKR

Exchange

Nasdaq Global Market

Price range

$5.00–$6.00

First filed

Jan 20, 2026

Latest amendment

Feb 13, 2026

Underwriters

Brookline and Arcadia

Sector

Biotech & pharma